Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 25.02M P/E - EPS this Y - Ern Qtrly Grth -
Income -15.7M Forward P/E - EPS next Y - 50D Avg Chg -7.00%
Sales 560 PEG - EPS past 5Y - 200D Avg Chg 6.00%
Dividend N/A Price/Book 1.46 EPS next 5Y - 52W High Chg -59.00%
Recommedations 2.00 Quick Ratio 0.32 Shares Outstanding 26.36M 52W Low Chg 108.00%
Insider Own - ROA -46.42% Shares Float 219M Beta 2.11
Inst Own 18.54% ROE -186.37% Shares Shorted/Prior 18.35K/242.79K Price 1.04
Gross Margin 100.00% Profit Margin - Avg. Volume 192,279 Target Price 2.01
Oper. Margin -148,056,740.00% Earnings Date Mar 27 Volume 54,015 Change -4.59%
About Kazia Therapeutics Limited

Kazia Therapeutics Limited operates as a biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/AKT/mTOR pathway, which is developed as a potential therapy for glioblastoma, diffuse intrinsic pontine glioma/advanced solid tumors, atypical teratoid rhabdoid tumor, brain metastases, triple negative breast cancer, and primary central nervous system lymphoma. It is also developing EVT801, a small molecule targeted therapeutic vascular endothelial growth factor receptor 3 inhibitor. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. The company was incorporated in 1994 and is based in Sydney, Australia.

Kazia Therapeutics Limited News
07:45 AM KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS
03/24/24 11 Best ASX Stocks To Buy Now
03/21/24 Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases
03/13/24 Kazia announces presentation of new data at AACR Annual Meeting
02/21/24 Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint
01/18/24 KAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS
12/05/23 Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering
08:00 AM Kazia Therapeutics Announces $2 Million Registered Direct Offering
11/29/23 KAZIA ANNOUNCES NON-BINDING LETTER OF INTENT FOR THE PROPOSED GRANTING OF RIGHTS TO DEVELOP AND COMMERCIALIZE PAXALISIB OUTSIDE OF ONCOLOGY
11/21/23 KAZIA PROVIDES OVERVIEW OF PAXALISIB RELATED PRESENTATIONS FROM THE SOCIETY OF NEURO-ONCOLOGY 2023 ANNUAL MEETING
11/20/23 KAZIA ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID NOTIFICATION
11/18/23 Kazia Therapeutics Limited's (NASDAQ:KZIA) large institutional owners must be happy as stock continues to impress, up 28% over the past week
11/15/23 KAZIA ANNOUNCES THE RELEASE OF PNOC022 CLINICAL STUDY ABSTRACT HIGHLIGHTING PAXALISIB IN DIFFUSE MIDLINE GLIOMA PATIENTS AHEAD OF THE SOCIETY OF NEURO-ONCOLOGY 2023 ANNUAL MEETING
11/10/23 KAZIA ANNOUNCES PUBLICATION IN MOLECULAR CANCER THERAPEUTICS HIGHLIGHTING PAXALISIB PRECLINICAL DATA IN MELANOMA
06:01 AM KAZIA THERAPEUTICS PROVIDES PRELIMINARY UPDATE FROM ONGOING PHASE 2 STUDY OF PAXALISIB IN PRIMARY CNS LYMPHOMA
10/23/23 KAZIA THERAPEUTICS ANNOUNCES CLINICAL DATA AT ESMO 2023 FROM ONGOING PHASE 1 EVT801 STUDY
10/11/23 Kazia announces voluntary delisting from ASX
10/05/23 KAZIA THERAPEUTICS ANNOUNCES PRESENTATIONS AT UPCOMING SCIENTIFIC MEETINGS
09/29/23 KAZIA THERAPEUTICS ANNOUNCES ACCEPTANCE OF LATE-BREAKING ABSTRACT AND ORAL PRESENTATION OF PNOC022 CLINICAL DATA AT 2023 SOCIETY FOR NEURO-ONCOLOGY ANNUAL MEETING
07/06/23 KAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA FOR TREATMENT OF SOLID TUMOR BRAIN METASTASES HARBORING PI3K PATHWAY MUTATIONS IN COMBINATION WITH RADIATION THERAPY
KZIA Chatroom

User Image FlowerPower80 Posted - 2 hours ago

$KZIA bought more today 🤷🏼‍♀️

User Image TimingTimingTiming Posted - 7 hours ago

$KZIA Question: ; How many of you took advantage of the Kazia crash today? In spite of being admittedly frustrated that this stock has no bottom, I continue to add regularly. Of course this is risky but also going to be quite rewarding if and when the stock finally runs. Most of my shares are in a ROTH, and I can afford to take more risk since I am not planning on retiring for at least 15 years or more. Anyways, just wondering about other investors here....are you buying this enormous dip, selling some, or holding?

User Image Slider19200000 Posted - 7 hours ago

$KZIA under $7.9M cap. i know we are waiting for GBM A results and the facts are we are about 40 months since the start of the study. with the original phase II trial, 16 months was superior to the current care. i am thinking the chances are the GBM results have to be comparable to the phase II with 40 months elapsed since start of the study and the last patient from what i recall was enroled about 21 months ago. Too bad we dont have a white night step forward and just buy 90-95% of the company in the open market as takeover and us smaller holders can go for the ride. we have seen those large volume days with good news announcements and the price goes down. we don need day traders.

User Image stayretired Posted - 8 hours ago

$KZIA Powell speaks. Market recovers. Kazia drops. ok....

User Image stayretired Posted - 11 hours ago

$KZIA shas ome more good news. Only phase 1, but speaks to our ability to execute and still NEVER fail any phase or trial.... https://www.prnewswire.com/news-releases/kazia-reports-successful-stage-1-completion-of-the-evt801-phase-1-clinical-trial-in-advanced-cancer-patients-302133011.html

User Image KarlWolf Posted - 11 hours ago

$KZIA may we here something about Pax https://x.com/almusella/status/1785678840309649519?s=46&t=f8leATVxEXYWhikTBCSq2w

User Image bertbertybert Posted - 11 hours ago

$KZIA reverse split going to rip your pants down

User Image BeeHawk Posted - 11 hours ago

$KZIA whoever is shorting a company trying to help children and others survive cancer should burn in hell. Honestly shorting micro cap biotech companies should be illegal. These evil bastards will do anything to make a quick buck. Disgusting.

User Image theonetowatch Posted - 11 hours ago

$KZIA https://www.prnewswire.com/news-releases/kazia-reports-successful-stage-1-completion-of-the-evt801-phase-1-clinical-trial-in-advanced-cancer-patients-302133011.html

User Image McGrupp Posted - 12 hours ago

$KZIA ATM goes brrrrrrrr, if you expected this news to be green, you are truly new to this shitco

User Image Jw242 Posted - 12 hours ago

$KZIA officially overweight 🤟

User Image Yankees23 Posted - 12 hours ago

$KZIA This phase 1 data shouldn’t be enough to raise or lower the SP. It’s nice but not meaningful enough to affect SP as its phase 1. So if this price drop is a result of this data its a major over reaction

User Image TimingTimingTiming Posted - 12 hours ago

$KZIA Well, looks like I have to keep selling other stocks to buy more of this fkn trash - jeez

User Image Itsmemario777 Posted - 12 hours ago

$KZIA wasn't that positive news?

User Image PT3 Posted - 12 hours ago

$KZIA just games… better management now and “ZERO” negative clinical results reported.

User Image bertbertybert Posted - 12 hours ago

$KZIA bunch of dreamers

User Image Dollar_D Posted - 12 hours ago

$KZIA what the fuck happened again?

User Image TimingTimingTiming Posted - 13 hours ago

$KZIA I’m up to 20,000 shares of this dog - don’t let us down K Z I A ! ! !

User Image futureexmillionare Posted - 13 hours ago

$KZIA They probably thought that they could sell more ATM in the morning . LOL . From no volume to 250k and stock doesn't even move. At this point do you guys thing AGILE news will move this stock ?

User Image KarlWolf Posted - 13 hours ago

$KZIA GBM AGILE, is ongoing, with final data expected in 1H2024. Tick Tock, Tick Tock

User Image futureexmillionare Posted - 13 hours ago

$KZIA Another good news. Unfortunately expect the stock to be down.. down...

User Image bigthicc Posted - 13 hours ago

$KZIA at least it didn’t go red…

User Image triplemintcookie Posted - 14 hours ago

$KZIA good news 801!!!!

User Image Jw242 Posted - 14 hours ago

$KZIA longs. Good or bad news?

User Image Stock_Titan Posted - 14 hours ago

$KZIA KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS https://www.stocktitan.net/news/KZIA/kazia-reports-successful-stage-1-completion-of-the-evt801-phase-1-4nni4yky18f3.html

User Image triplemintcookie Posted - 15 hours ago

$KZIA AGILE update today? Hopefully something said positive Kazia.

User Image FlowerPower80 Posted - 04/30/24

$KZIA where is @Jw242???

User Image TimingTimingTiming Posted - 04/30/24

$KZIA Welp, just bought 5000 more shares.

User Image Yankees23 Posted - 04/30/24

$KZIA To put this into context at approximately 10:39 am Eastern time KZIA is down 1.5 cents on 32,000 shares traded. This is less than $11,500 worth of shares traded.

User Image KarlWolf Posted - 04/30/24

$KZIA lol again that 1 share 8% up pm dude

Analyst Ratings
HC Wainwright & Co. Buy Apr 11, 23
Maxim Group Hold Aug 2, 22
HC Wainwright & Co. Neutral Aug 2, 22
Maxim Group Buy Oct 14, 21
HC Wainwright & Co. Buy Jan 5, 21